All citations on this page refer to pre-clinical and peer-reviewed research and do not constitute a claim of safety or therapeutic efficacy
Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients
The main treatment strategies include acidosis correction, oxidative stress injury prevention, and the treatment of manifestations
Bucci L, Yani SL, Fabbri C, Bijlsma AY, Maier AB, Meskers CG, Narici MV, Jones DA, McPhee JS, Seppet E, Gapeyeva H, Paasuke M, Sipila S, Kovanen V, Stenroth L, Musaro A, Hogrel JY, Barnouin Y, Butler-Browne G, Capri M, Franceschi C, Salvioli S
Consult a healthcare provider.